Suppr超能文献

在越南的疫情爆发中使用口服霍乱疫苗:一项病例对照研究。

Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

机构信息

National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam.

出版信息

PLoS Negl Trop Dis. 2011 Jan 25;5(1):e1006. doi: 10.1371/journal.pntd.0001006.

Abstract

BACKGROUND

Killed oral cholera vaccines (OCVs) are available but not used routinely for cholera control except in Vietnam, which produces its own vaccine. In 2007-2008, unprecedented cholera outbreaks occurred in the capital, Hanoi, prompting immunization in two districts. In an outbreak investigation, we assessed the effectiveness of killed OCV use after a cholera outbreak began.

METHODOLOGY/PRINCIPAL FINDINGS: From 16 to 28 January 2008, vaccination campaigns with the Vietnamese killed OCV were held in two districts of Hanoi. No cholera cases were detected from 5 February to 4 March 2008, after which cases were again identified. Beginning 8 April 2008, residents of four districts of Hanoi admitted to one of five hospitals for acute diarrhea with onset after 5 March 2008 were recruited for a matched, hospital-based, case-control outbreak investigation. Cases were matched by hospital, admission date, district, gender, and age to controls admitted for non-diarrheal conditions. Subjects from the two vaccinated districts were evaluated to determine vaccine effectiveness. 54 case-control pairs from the vaccinated districts were included in the analysis. There were 8 (15%) and 16 (30%) vaccine recipients among cases and controls, respectively. The vaccine was 76% protective against cholera in this setting (95% CI 5% to 94%, P = 0.042) after adjusting for intake of dog meat or raw vegetables and not drinking boiled or bottled water most of the time.

CONCLUSIONS/SIGNIFICANCE: This is the first study to explore the effectiveness of the reactive use of killed OCVs during a cholera outbreak. Our findings suggest that killed OCVs may have a role in controlling cholera outbreaks.

摘要

背景

已研发出灭活口服霍乱疫苗(killed oral cholera vaccine,killed OCV),但除越南以外,其他国家并未常规使用灭活 OCV 来控制霍乱,因为越南有自己生产的疫苗。2007-2008 年,首都河内暴发了前所未有的霍乱疫情,促使两个区开展了免疫接种。在一次暴发调查中,我们评估了在霍乱暴发开始后使用灭活 OCV 的效果。

方法/主要发现:2008 年 1 月 16 日至 28 日,在河内的两个区开展了用越南生产的灭活 OCV 进行的疫苗接种运动。2008 年 2 月 5 日至 3 月 4 日未发现霍乱病例,此后又发现了病例。自 2008 年 4 月 8 日起,在河内的四个区居住并因 2008 年 3 月 5 日后发病而入住了 5 家医院之一的急性腹泻患者被招募入组进行一项基于医院的匹配病例对照暴发调查。病例按医院、入院日期、区、性别和年龄与因非腹泻疾病入院的对照进行匹配。评估来自两个接种区的受试者以确定疫苗效果。对来自接种区的 54 对病例对照进行了分析。病例组和对照组中分别有 8 例(15%)和 16 例(30%)疫苗接种者。在校正食用狗肉或生蔬菜以及多数时间不饮用开水或瓶装水的因素后,疫苗在该环境中的保护效力为 76%(95%CI,5%至 94%,P=0.042)。

结论/意义:这是第一项探索在霍乱暴发期间有针对性地使用灭活 OCV 的效果的研究。我们的发现表明,灭活 OCV 可能在控制霍乱暴发方面发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfb/3026769/4eefb59af0cf/pntd.0001006.g001.jpg

相似文献

1
Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.
PLoS Negl Trop Dis. 2011 Jan 25;5(1):e1006. doi: 10.1371/journal.pntd.0001006.
2
Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Lancet. 1997 Jan 25;349(9047):231-5. doi: 10.1016/s0140-6736(96)06107-7.
3
Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam.
Vaccine. 2006 May 15;24(20):4297-303. doi: 10.1016/j.vaccine.2006.03.008. Epub 2006 Mar 20.
4
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.
6
Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
Lancet Infect Dis. 2021 Oct;21(10):1407-1414. doi: 10.1016/S1473-3099(20)30781-7. Epub 2021 Jun 16.
7
Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
Int J Epidemiol. 2019 Aug 1;48(4):1252-1261. doi: 10.1093/ije/dyz060.
9
The case for reactive mass oral cholera vaccinations.
PLoS Negl Trop Dis. 2011 Jan 25;5(1):e952. doi: 10.1371/journal.pntd.0000952.
10

引用本文的文献

1
Modelling the impact of vaccination on cholera transmission dynamics under stratified populations and seasonality.
Infect Dis Model. 2025 Jun 23;10(4):1138-1152. doi: 10.1016/j.idm.2025.06.006. eCollection 2025 Dec.
2
Assessment of Management Factors Influencing Vaccination Against Cholera in the Health District of Katana, the Democratic Republic of the Congo.
Health Serv Insights. 2025 Feb 7;18:11786329251316675. doi: 10.1177/11786329251316675. eCollection 2025.
5
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration .
Front Immunol. 2022 Jan 27;13:746484. doi: 10.3389/fimmu.2022.746484. eCollection 2022.
6
Oral Cholera Vaccine Efficacy and Effectiveness.
Vaccines (Basel). 2021 Dec 15;9(12):1482. doi: 10.3390/vaccines9121482.
7
Global oral cholera vaccine use, 2013-2018.
Vaccine. 2020 Feb 29;38 Suppl 1(Suppl 1):A132-A140. doi: 10.1016/j.vaccine.2019.08.086. Epub 2019 Sep 10.
8
The cholera outbreak in Yemen: lessons learned and way forward.
BMC Public Health. 2018 Dec 4;18(1):1338. doi: 10.1186/s12889-018-6227-6.
9
Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis.
J Infect Dis. 2018 Oct 15;218(suppl_3):S154-S164. doi: 10.1093/infdis/jiy444.

本文引用的文献

1
Cholera vaccines: WHO position paper.
Wkly Epidemiol Rec. 2010 Mar 26;85(13):117-28.
2
Evolution of new variants of Vibrio cholerae O1.
Trends Microbiol. 2010 Jan;18(1):46-54. doi: 10.1016/j.tim.2009.10.003. Epub 2009 Nov 26.
5
El Tor cholera with severe disease: a new threat to Asia and beyond.
Epidemiol Infect. 2010 Mar;138(3):347-52. doi: 10.1017/S0950268809990550. Epub 2009 Aug 14.
6
Cholera: global surveillance summary, 2008.
Wkly Epidemiol Rec. 2009 Jul 31;84(31):309-24.
7
Public health. The cholera crisis in Africa.
Science. 2009 May 15;324(5929):885. doi: 10.1126/science.1173890.
10
Temporal trends and climatic factors associated with bacterial enteric diseases in Vietnam, 1991-2001.
Environ Health Perspect. 2008 Jan;116(1):7-12. doi: 10.1289/ehp.9658.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验